Scientists Just Found Stray Vials of Smallpox From the 1950s

Microbiologist Tatiana Travis works with tubes of bacteria samples in an antimicrobial resistance and characterization lab within the Infectious Disease Laboratory at the federal Centers for Disease Control and Prevention. Microbiologist Tatiana Travis works with tubes of bacteria samples in an antimicrobial resistance and characterization lab within the Infectious Disease Laboratory at the federal Centers for Disease Control and Prevention. David Goldman/AP

If there's one thing you generally want to keep tabs on, it's a deadly virus that has killed an estimated 300 million people in the 20th century alone.

But a few vials of smallpox, which was officially declared eradicated worldwide in 1979, managed to go unnoticed for decades in a storage room, according to a statement by the Centers for Disease Control and Prevention on Tuesday.

On July 1, officials from the National Institutes of Health told the CDC's Division of Select Agents and Toxins that employees had discovered vials labeled "variola," the Latin name of smallpox, on the NIH's Bethesda campus in Maryland. The samples, which appear to be from the 1950s, were found in an unused section of a storage room in a Food and Drug Administration laboratory.

Scientists stumbled upon the vials as they prepped for the laboratory's move to the FDA's main campus in Silver Spring, Md. The FDA has operated this laboratory, among others, on NIH's campus since 1972.

The vials were immediately rushed to a CDC-registered agent-containment laboratory in Bethesda. They were transported to a CDC high-containment facility in Atlanta on Thursday, accompanied by federal and local law-enforcement agencies and, we hope, stored in a very large box. In the next two weeks, scientists will test the smallpox virus inside the vials to determine whether it's viable—that is, whether it can grow in a petri dish of tissue culture. After that, all of the vials will be destroyed.

Only two samples of the smallpox disease remain in the world. One is held at CDC headquarters in Atlanta, and the other at the State Research Centre of Virology and Biotechnology in Novosibirsk, Russia. More than 30 years after eradication, the debate over whether these samples should still exist continues. Opponents of continued storage say there's no real reason to hang onto the clearly hazardous samples. Why keep the risk alive? Supporters of storage say the samples could be useful in further research, in case the virus still exists elsewhere and resurfaces as a biological weapon.

The last medical case of smallpox in the United States was in 1949.

Following the discovery in Maryland, the CDC has invited the World Health Organization, which oversees the security of existing smallpox repositories, into its investigation of the samples. The CDC's Division of Select Agents and Toxins and the FBI are looking into how these samples got there. May we suggest looking at the intern first?

Stay up-to-date with federal news alerts and analysis — Sign up for GovExec's email newsletters.
Close [ x ] More from GovExec

Thank you for subscribing to newsletters from
We think these reports might interest you:

  • Sponsored by G Suite

    Cross-Agency Teamwork, Anytime and Anywhere

    Dan McCrae, director of IT service delivery division, National Oceanic and Atmospheric Administration (NOAA)

  • Data-Centric Security vs. Database-Level Security

    Database-level encryption had its origins in the 1990s and early 2000s in response to very basic risks which largely revolved around the theft of servers, backup tapes and other physical-layer assets. As noted in Verizon’s 2014, Data Breach Investigations Report (DBIR)1, threats today are far more advanced and dangerous.

  • Federal IT Applications: Assessing Government's Core Drivers

    In order to better understand the current state of external and internal-facing agency workplace applications, Government Business Council (GBC) and Riverbed undertook an in-depth research study of federal employees. Overall, survey findings indicate that federal IT applications still face a gamut of challenges with regard to quality, reliability, and performance management.

  • PIV- I And Multifactor Authentication: The Best Defense for Federal Government Contractors

    This white paper explores NIST SP 800-171 and why compliance is critical to federal government contractors, especially those that work with the Department of Defense, as well as how leveraging PIV-I credentialing with multifactor authentication can be used as a defense against cyberattacks

  • Toward A More Innovative Government

    This research study aims to understand how state and local leaders regard their agency’s innovation efforts and what they are doing to overcome the challenges they face in successfully implementing these efforts.

  • From Volume to Value: UK’s NHS Digital Provides U.S. Healthcare Agencies A Roadmap For Value-Based Payment Models

    The U.S. healthcare industry is rapidly moving away from traditional fee-for-service models and towards value-based purchasing that reimburses physicians for quality of care in place of frequency of care.

  • GBC Flash Poll: Is Your Agency Safe?

    Federal leaders weigh in on the state of information security


When you download a report, your information may be shared with the underwriters of that document.